Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin Waschki, Peter Alter, Tanja Zeller, Christina Magnussen, Johannes T. Neumann, Raphael Twerenbold, Christoph Sinning, Christian Herr, Kathrin Kahnert, Sebastian Fähndrich, Stefan Blankenberg, Klaus F. Rabe, Tobias Welte, Rudolf A. Jörres, Claus F. Vogelmeier, Robert Bals, Henrik Watz. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study. Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019

Member's Comments

No comment yet.

Related content which might interest you: Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Late Breaking Abstract - High-sensitivity troponin I predicts all-cause mortality in stable COPD in the COSYCONET cohort Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Troponin as a biomarker for mortality in stable COPD Source: Eur Respir J, 55 (2) 1902447; 10.1183/13993003.02447-2019 Year: 2020 hsCRP is associated with 10-year mortality in COPD. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Elevated cardiac troponin predicts 11-year mortality in COPD Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis Source: Eur Respir Rev 2017; 26: 160070 Year: 2017 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Procalcitonin and proadrenomedullin in COPD patients: Stable state versus exacerbation difference in mortality rate? Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis Source: Eur Respir Rev, 29 (156) 190166; 10.1183/16000617.0166-2019 Year: 2020 LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019